A hedge fund board member at CVS has been busy. Lawrence Robbins filed sales totalling over $320 million in CVS shares across three days in mid-May. The filings hit regulators on May 21. Robbins sits on the CVS board through his hedge fund position. CVS's CTO Tilak Mandadi also sold $6.2 million worth of stock earlier this month. A director added another $2.9 million in sales. The wave of selling comes as CVS continues its turnaround effort under pressure from investors.
At ARM Holdings, the sell-off is broader. Multiple C-suite officers dumped shares throughout May. Chief Legal Officer Spencer Collins sold over $8.5 million across several transactions filed on May 13. Colleagues William Abbey and Charlotte Eaton added further sales totalling over $5 million combined, filed last week. That is four ARM executives reducing exposure over a single month.
On the buy side, Norwegian Cruise Line CEO John Chidsey stepped up. He filed a $2.5 million personal purchase in NCLH shares on May 26. The trade covered 153,000 shares at roughly $16.40 each. CEO purchases of that size tend to signal confidence in a recovery.
TXO Partners founder Bob Simpson also kept buying. Simpson filed two purchases in TXO totalling nearly this week alone, continuing a pattern of accumulation in the oil and gas partnership he chairs.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
